CD274 and hepatocellular carcinoma: The present study (A) identified overexpression of PD-L1 as an independent predictor for postoperative recurrence in patients at high risk of HCC relapse who received adjuvant sorafenib after curative resection, (B) detected no significant difference in outcomes between patients with or without adjuvant sorafenib treatment.